Reno-cerebrovascular disease: linking the nephron and neuron

被引:13
作者
Lee, Meng [3 ,4 ,5 ]
Ovbiagele, Bruce [1 ,2 ]
机构
[1] Univ Calif San Diego, Stroke Ctr, La Jolla, CA 92037 USA
[2] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92037 USA
[3] Univ Calif Los Angeles, Stroke Ctr, Los Angeles, CA USA
[4] Chang Gung Mem Hosp, Taipei 10591, Taiwan
[5] Chang Gung Univ, Taipei, Taiwan
关键词
albuminuria; chronic kidney disease; CKD; creatinine clearance; cystatin C; glomerular filtration rate; incidence; microalbuminuria; outcomes; prevalence; prognosis; proteinuria; renal function; stroke; urinary albumin excretion; CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; URINARY ALBUMIN EXCRETION; CEREBRAL-ARTERY STENOSIS; SILENT BRAIN INFARCTION; SERUM CYSTATIN-C; CARDIOVASCULAR-DISEASE; RISK-FACTOR; COGNITIVE IMPAIRMENT; NONDIABETIC PATIENTS;
D O I
10.1586/ERN.10.204
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Chronic kidney disease (CKD), a growing public health concern, carries a substantial burden and is a well-known independent predictor of coronary artery disease outcomes. In the last few years, attention has been focused on various CKD indices and their prognostic impact among individuals with, or at risk for, cerebrovascular disease. Mounting evidence suggests that the presence of CKD in various forms (filtration rate and barrier impairments), and even at mild stages, is associated with surrogate cerebrovascular disease markers, confers higher future risk of ischemic and hemorrhagic cerebrovascular events, and predicts poor clinical outcomes after an index stroke. However, a better understanding of these links is required. For instance, the direction and strength of the association of CKD with a heterogeneous vascular disease entity, such as cerebrovascular disease (vs coronary artery disease), appears to be greatly influenced by stroke type and ischemic stroke subtype, as well as CKD index and CKD stage. Furthermore, the potential mechanisms underlying the independent relation of baseline CKD and stroke risk need to be better delineated, since a causal association cannot be assumed. Additional investigation is also warranted to clarify whether CKD indices can usefully enhance cerebrovascular disease stratification beyond traditional risk factors. In the meantime, with several recent systematic reviews of published evidence supporting a robust and independent association of CKD with subsequent cerebrovascular disease risk, optimal implementation of established stroke risk reduction strategies in individuals with CKD might improve stroke outcomes. This article summarizes the compelling epidemiological and clinical evidence relating CKD to stroke, and presents the rationale for conducting future studies to assess the role of CKD as a risk marker or potential therapeutic target in individuals with, or at risk for, stroke.
引用
收藏
页码:241 / 249
页数:9
相关论文
共 60 条
[1]   Albuminuria and the risk of incident stroke and stroke types in older adults [J].
Aguilar, M. I. ;
O'Meara, E. S. ;
Seliger, S. ;
Longstreth, W. T., Jr. ;
Hart, R. G. ;
Pergola, P. E. ;
Shlipak, M. G. ;
Katz, R. ;
Sarnak, M. J. ;
Rifkin, D. E. .
NEUROLOGY, 2010, 75 (15) :1343-1350
[2]   Relation of baseline presence and severity of renal disease to long-term mortality in persons with known stroke [J].
Ani, Chinbam ;
Ovbiagele, Bruce .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2010, 288 (1-2) :123-128
[3]   Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria [J].
Asselbergs, FW ;
Diercks, GFH ;
Hillege, HL ;
van Boven, AJ ;
Janssen, WMT ;
Voors, AA ;
de Zeeuw, D ;
de Jong, PE ;
van Veldhuisen, DJ ;
van Gilst, WH .
CIRCULATION, 2004, 110 (18) :2809-2816
[4]  
BAIGENT C, RESULTS STUDY HEART
[5]   Silent MRI infarcts and the risk of future stroke - The cardiovascular health study [J].
Bernick, C ;
Kuller, L ;
Dulberg, C ;
Longstreth, WT ;
Manolio, T ;
Beauchamp, N ;
Price, T .
NEUROLOGY, 2001, 57 (07) :1222-1229
[6]   LEFT-VENTRICULAR MASS AND RISK OF STROKE IN AN ELDERLY COHORT - THE FRAMINGHAM HEART-STUDY [J].
BIKKINA, M ;
LEVY, D ;
EVANS, JC ;
LARSON, MG ;
BENJAMIN, EJ ;
WOLF, PA ;
CASTELLI, WP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (01) :33-36
[7]   Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease - A science advisory from the American Heart Association Kidney and Cardiovascular Disease Council; the councils on high blood pressure research, cardiovascular disease in the young, and epidemiology and prevention; and the quality of care and outcomes research interdisciplinary working group [J].
Brosius, Frank C., III ;
Hostetter, Thomas H. ;
Kelepouris, Ellie ;
Mitsnefes, Mark M. ;
Moe, Sharon M. ;
Moore, Michael A. ;
Pennathur, Subramaniam ;
Smith, Grace L. ;
Wilson, Peter W. F. .
CIRCULATION, 2006, 114 (10) :1083-1087
[8]   Mortality Risks for All Causes and Cardiovascular Diseases and Reduced GFR in a Middle-aged Working Population in Taiwan [J].
Cheng, Ting-Yuan David ;
Wen, Sung-Feng ;
Astor, Brad C. ;
Tao, Xuguang ;
Samet, Jonathan M. ;
Wen, Chi Pang .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 52 (06) :1051-1060
[9]   Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment [J].
Coll, E ;
Botey, A ;
Alvarez, L ;
Poch, E ;
Quintó, L ;
Saurina, A ;
Vera, M ;
Piera, C ;
Darnell, A .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (01) :29-34
[10]   MYELOPEROXIDASE, A CATALYST FOR LIPOPROTEIN OXIDATION, IS EXPRESSED IN HUMAN ATHEROSCLEROTIC LESIONS [J].
DAUGHERTY, A ;
DUNN, JL ;
RATERI, DL ;
HEINECKE, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (01) :437-444